HOOK: Hookipa Pharma Inc Company Profile & Statistics

About

HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company. It is engaged in developing a class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform which is designed to reprogram the body's immune system. HOOKIPA Pharma Inc. is based in New York, United States.

Info & Links

CEO

Joern Aldag

Headquarters

350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
NEW YORK, NY 10118, UNITED STATES

Auditor

PwC Wirtschaftspr¿fung GmbH

Share holders

Employees

179

Hookipa Pharma Inc Statistics

Valuation Measures

Market Capitalization²

24.72M

Enterprise Value

-35.03M

Enterprise Value/EBITDA(ttm)

0.61

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.51

Price to Book(mrq)

0.36

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-58.67%

Profit Margin(ttm)

-517.57%

Return on Equity(ttm)

-33.31%

Return on Invested Capital(ttm)

-55.32%

Return on Assets(ttm)

-21.65%

Income Statement

Revenue(ttm)

50.00M

Revenue Per Share(ttm)

4.15

Gross Profit(ttm)

50.00M

EBITDA(ttm)³

-57.56M

Net Income Available to Common(ttm)

-43.37M

Diluted EPS(ttm)

-3.72

Share Statistics

Beta (5Y Monthly)

0.71

52-Week Change

-64.95%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

12.05M

Dividend Yield

0.00%

Float⁴

11.66M

% Held by Insiders

3.30%

% Held by Institutions

63.88%

Balance Sheet

Total Cash(mrq)

59.75M

Total Cash Per Share(mrq)

4.96

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.26%

Quick Ratio(mrq)

3.26%

Book Value Per Share(mrq)

5.96

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.66

Free Cash Flow(ytd)

-56.23M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

HOOK

Hookipa Pharma Inc

Hookipa Pharma Inc Profile